In a highly anticipated announcement, the U.S. Food and Drug Administration on Monday, June 7, approved the first new drug for Alzheimer’s disease in nearly two […]
While significant attention has been paid to COVID-19 deaths in nursing homes, public health leaders have understood less about the effects of the virus in assisted […]
Since the first diagnosed case of COVID-19 in the United States on Jan. 20, 2020, news about infection rates, deaths and pandemic-driven economic hardships has been […]